Prostate Cancer - Results from #2840

Metastatic Prostate Cancers with BRCA2 versus ATM Mutations Exhibit Divergent Molecular Features and Clinical Outcomes. May 2, 2023

Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial. May 2, 2023

Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer. May 2, 2023

XTANDI® (enzalutamide) plus Leuprolide Reduced the Risk of Metastasis by 58% in Non-Metastatic Hormone-Sensitive Prostate Cancer versus Placebo plus Leuprolide May 1, 2023

Observation, Radiotherapy, or Radical Prostatectomy for Localized Prostate Cancer: Survival Analysis in the United States. May 1, 2023

The relationship between biochemical recurrence and number of lymph nodes removed during surgery for localized prostate cancer. May 1, 2023

Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review. May 1, 2023

Strategies used in managing conversations about prostate-specific antigen (PSA) testing among family physicians (FPs): a qualitative study. May 1, 2023

Implementation and Evaluation of an Intelligent Automatic Treatment Planning Robot for Prostate Cancer Stereotactic Body Radiation Therapy. May 1, 2023

Emerging treatment options for prostate cancer. April 28, 2023

A Systematic Review of the Variability in Performing and Reporting Intraprostatic Prostate-specific Membrane Antigen Positron Emission Tomography in Primary Staging Studies. April 28, 2023

Decade-long trends in prostate cancer biopsy grade groups and treatment within a population-based registry. April 28, 2023

Detecting localised prostate cancer using radiomic features in PSMA PET and multiparametric MRI for biologically targeted radiation therapy. April 28, 2023

Stability of Prognostic Estimation Using the CAPRA Score Incorporating Imaging-Based vs Physical Exam-Based Staging. April 28, 2023

Prognostic Value of the Intermediate-risk Feature in Men with Favorable Intermediate-risk Prostate Cancer: Implications for Active Surveillance. April 28, 2023

Prevalence and Risk Factors of Emotional Distress in Patients With Prostate Cancer Assigned to External-beam Radiotherapy With or Without High-dose Rate Brachytherapy. April 27, 2023

Time from biopsy to radical prostatectomy by race in an equal-access healthcare system: Results from the SEARCH cohort. April 27, 2023

Visceral Metastasis Predicts Response to New Hormonal Agents in Metastatic Castration-Sensitive Prostate Cancer. April 27, 2023

Role of radiomic analysis of [18F]fluoromethylcholine PET/CT in predicting biochemical recurrence in a cohort of intermediate and high risk prostate cancer patients at initial staging. April 27, 2023

Prevalence of Shared Decision-making in Prostate Cancer Screening in New York State. April 27, 2023

Page 143 of 1439